ReGenesys is a biopharmaceutical company focused on the research and development of stem cell based therapies to address unmet needs. The team conducts basic and applied research related to product characterization, performance and manufacturing. Additionally, ReGenesys has responsibility for the European development of MultiStem® cells. MultiStem® is a cryopreserved allogeneic cell product that is being used in several clinical trials.
ReGenesys is a wholly-owned subsidiary of Athersys, a publicly held biotechnology company located in Cleveland, Ohio (NASDAQ: ATHX).